Cargando…

Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With Diabetes

OBJECTIVE: Advances in continuous glucose monitoring (CGM) have transformed ambulatory diabetes management. Until recently, inpatient use of CGM has remained investigational, with limited data on its accuracy in the hospital setting. RESEARCH DESIGN AND METHODS: To analyze the accuracy of Dexcom G6,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Georgia M., Spanakis, Elias K., Migdal, Alexandra L., Singh, Lakshmi G., Albury, Bonnie, Urrutia, Maria Agustina, Zamudio-Coronado, K. Walkiria, Scott, William H., Doerfler, Rebecca, Lizama, Sergio, Satyarengga, Medha, Munir, Kashif, Galindo, Rodolfo J., Vellanki, Priyathama, Cardona, Saumeth, Pasquel, Francisco J., Peng, Limin, Umpierrez, Guillermo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Emerging Technologies: Data Systems and Devices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323182/ https://www.ncbi.nlm.nih.gov/pubmed/34099515 http://dx.doi.org/10.2337/dc20-2856

Ejemplares similares

Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen
por: Galindo, Rodolfo J., et al.
Publicado: (2020)

Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis
por: Galindo, Rodolfo J, et al.
Publicado: (2020)

Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery
por: Cardona, Saumeth, et al.
Publicado: (2019)

Clinical characteristics and outcomes of symptomatic and asymptomatic hypoglycemia in hospitalized patients with diabetes
por: Cardona, Saumeth, et al.
Publicado: (2018)

Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial
por: Singh, Lakshmi G., et al.
Publicado: (2020)

Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial
por: Umpierrez, Guillermo, et al.
Publicado: (2015)

MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy
por: Satyarengga, Medha, et al.
Publicado: (2020)

Increasing Hospitalizations for DKA: A Need for Prevention Programs
por: Vellanki, Priyathama, et al.
Publicado: (2018)

Diabetic ketoacidosis risk during the COVID-19 pandemic
por: Vellanki, Priyathama, et al.
Publicado: (2021)

Predictive Value of Admission Hemoglobin A(1c) on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes
por: Pasquel, Francisco J., et al.
Publicado: (2015)

Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes
por: Vellanki, Priyathama, et al.
Publicado: (2015)

RF28 | PSUN184 New American Diabetes Association Definition of Diabetes Remission Does not Correlate with Time in Remission in Ketosis-Prone Diabetes
por: Oladejo, Omolade, et al.
Publicado: (2022)

Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises
por: Vellanki, Priyathama, et al.
Publicado: (2020)

PSUN191 Hospital Outcomes of Intensive and Standard Inpatient Glycemic Targets: A Propensity Scored-Matched Post Hoc Analysis of Insulin-Treated Patients with Type 2 Diabetes
por: Fafyman, Maya, et al.
Publicado: (2022)

Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631–1638
por: Galindo, Rodolfo J., et al.
Publicado: (2019)

Impact of obesity on hospital complications and mortality in hospitalized patients with hyperglycemia and diabetes
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2016)

Use of a Noninvasive Continuous Monitoring Device in the Management of Atrial Fibrillation: A Pilot Study
por: Rosenberg, Michael A, et al.
Publicado: (2013)

Medium-Term Effects of Septal and Apical Pacing in Pacemaker-Dependent Patients: A Double-Blind Prospective Randomized Study
por: Molina, Luis, et al.
Publicado: (2014)

Long-Term Follow-Up of Patients with Chronic Chagas Disease and Implantable Cardioverter-Defibrillator
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2014)

Right Ventricular Anatomy Can Accommodate Multiple Micra Transcatheter Pacemakers
por: OMDAHL, PAMELA, et al.
Publicado: (2016)

R-Wave Sensing in an Implantable Cardiac Monitor without ECG-Based Preimplant Mapping: Results from a Multicenter Clinical Trial
por: Krahn, Andrew D, et al.
Publicado: (2014)

Distinct impacts of heart rate and right atrial‐pacing on left atrial mechanical activation and optimal AV delay in CRT
por: Kyriacou, Andreas, et al.
Publicado: (2018)

Echocardiographic Guidance of the Novel WaveCrest Left Atrial Appendage Occlusion Device
por: Vainrib, Alan F., et al.
Publicado: (2018)

Improvement of Right Ventricular Hemodynamics with Left Ventricular Endocardial Pacing during Cardiac Resynchronization Therapy
por: HYDE, EOIN R., et al.
Publicado: (2016)

Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020)

Percutaneous Left Atrial Appendage Occlusion: A View From the UK
por: Ding, Wern Yew, et al.
Publicado: (2020)

Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmias
por: Crossley, George H., et al.
Publicado: (2019)

Long‐term outcomes of cardiac resynchronization therapy in adult congenital heart disease
por: Leyva, Francisco, et al.
Publicado: (2019)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Leadless pacing: Going for the jugular
por: Saleem‐Talib, Shmaila, et al.
Publicado: (2019)

Longevity decoded: Insights from power consumption analyses into device construction and their clinical implications
por: Lau, Ernest W.
Publicado: (2019)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
por: Broers, Eva R., et al.
Publicado: (2019)

Clinical evaluation of a small implantable cardiac monitor with a long sensing vector
por: Piorkowski, Christopher, et al.
Publicado: (2019)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

Anti-thrombogenic coatings for devices in neurointerventional surgery: Case report and review of the literature
por: Henkes, Hans, et al.
Publicado: (2019)

Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular‐matrix envelope
por: Sohail, M. Rizwan, et al.
Publicado: (2020)

LBBAP in patients with normal intrinsic QRS duration: Electrical and mechanical characteristics
por: Wang, Shaoxian, et al.
Publicado: (2021)

Cardiac resynchronization therapy with intraoperative epicardial mapping via minithoracotomy: 10 years’ experience
por: Hejjel, László, et al.
Publicado: (2020)

Accuracy of arrhythmia detection in implantable cardiac monitors: A prospective randomized clinical trial comparing Reveal LINQ and Confirm Rx
por: Ip, John, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7c7lbecrk2qh6fr5d8nlbq3kfo